Gaps in surveillance, testing, sequencing, and vaccination for COVID-19 could create the perfect storm for a new variant.
Matthew W. Reynolds, Ph.D., vice president, scientific affairs, real world solutions, IQVIA, explains how RWE can provide a greater picture of a disease’s progression as well as a blueprint for future outbreaks.
Dr. Anthony Fauci, the U.S. health official celebrated and vilified as the face of the country’s COVID-19 pandemic response, used his final White House briefing on Tuesday to denounce division and promote vaccines.
Regulators in Japan had previously denied emergency approval for the Shionogi pill, saying they wanted to see more data on its effectiveness. There were also concerns the drug could pose risk to pregnancies, based on results from animal studies.
The company cited Gavi’s failure to procure the 350 million doses it had agreed to buy in May last year for the COVAX facility.
With reproductive rights under attack and professional and personal challenges escalated as a result of the pandemic, women have been collectively called on to lead with not just authenticity, but also with compassion, kindness, and empathy. “In times of crisis, women take center stage. We are the peace makers, the solution seekers, the voice amplifiers,” said HBA interim CEO Wendy White at the 2022 HBA Annual Conference.
Pharmaceutical companies could be made to disclose prices and deals agreed for any products they make to fight future global health emergencies, under new rules that would govern a World Health Organization-backed pandemic accord reviewed by Reuters.
Infections from some antibiotic-resistant pathogens known as superbugs have more than doubled in health care facilities in Europe, an EU agency said on Thursday, providing further evidence of the wider impact of the COVID-19 pandemic.
Moderna Inc. said its Omicron-tailored vaccines produced a better immune response against the BA.4/5 subvariants in a mid-to-late stage study, when given as a booster dose, compared with its original shot.
Reports of heavy periods – bleeding characterized by increased volume and/or duration that interferes with the quality of life – have been observed during clinical trials, from cases in the real world and in medical literature, according to the European Medicines Agency.